Evidence map›Paper›PMID 20195789›Full record

ArticleObesity surgery2010

The relationships between IGF-1 and CRP, NO, leptin, and adiponectin during weight loss in the morbidly obese.

Eva Pardina, Roser Ferrer, Juan Antonio Baena-Fustegueras, Albert Lecube, Jose Manuel Fort, Víctor Vargas, Roberto Catalán, Julia Peinado-Onsurbe

Abstract read
PubMed Publisher
In one paragraph

Article in Obesity surgery, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed, 1 pooled it
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 1 synthesis or guideline pooled it, 69 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Article
  7. Review
  8. Analysis of the adiponectin paradox in healthy older people.Journal of cachexia, sarcopenia and muscle · 2023
    Article
  9. Leptin signaling and leptin resistance.Medical review (2021) · 2022
    Review
  10. Article
  11. Article
  12. Anti-Obesity Effect of Extract fromFoods (Basel, Switzerland) · 2019
    Article
  13. Article
  14. A Functional Interplay between IGF-1 and Adiponectin.International journal of molecular sciences · 2017
    Review
  15. Article
  16. Article
  17. Article
  18. Observational
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Eva PardinaBiochemistry and Molecular Biology Department, Biology Faculty, Barcelona University, Barcelona, Spain.
Roser Ferrer
Juan Antonio Baena-Fustegueras
Albert Lecube
Jose Manuel Fort
Víctor Vargas
Roberto Catalán
Julia Peinado-Onsurbe
Universitat Autònoma de Barcelona · ESUniversitat de Barcelona · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe relationship between C-reactive protein (CRP), nitric oxide (NO), leptin, adiponectin, and insulin growth factor 1 (IGF-1) is poorly defined in morbidly obese patients before and after gastric bypass and, in some cases, is controversial.

methodsWe examined the plasma of 34 morbidly obese patients before and 1, 6, and 12 months after Roux-en-Y gastric bypass surgery.

resultsObese people had more CRP (21.3 +/- 1.8 microg/ml) and leptin (36.9 +/- 4.0 ng/ml) than those in the control group (nonobese people: CRP = 6.9 +/- 0.9 microg/ml, p < 0.0001; leptin = 7.5 +/- 0.4 ng/ml, p < 0.0001). However, they had less NO (30.4 +/- 2.7 nmol/ml), IGF-1 (77.5 +/- 6.6 ng/ml), and adiponectin (11.1 +/- 1.0 microg/ml) than those in the control group (NO = 45.8 +/- 3.9 nmol/ml, p = 0.0059; IGF-1 = 202.0 +/- 12.0 ng/ml, p < 0.0001; adiponectin = 18.0 +/- 2.0 microg/ml, p < 0.0001). During weight loss, the amount of CRP and leptin decreased until they reached the nonobese values, but the level of NO remained lower than in nonobese people, even 1 year after surgery. The linear regression slopes were negative and very significant for leptin (p = 0.0005) and CRP (p = 0.0018) but were less significant for NO (p = 0.0221). IGF-1 displayed a very good linear regression (both negative and significant) with some anthropometric parameters, including body mass index (p = 0.0025), total fat (p = 0.0177), and the percentage of fat (p < 0.0001).

conclusionFor the first time, we report the relationship between IGF-1 and CRP, NO, leptin, and adiponectin. For all these parameters, the best and most widely demonstrated improvements in comorbidities before and during weight loss in morbid obesity were associated with CRP and leptin.

Indexed as

AdiponectinAdultBody Mass IndexC-Reactive ProteinFemaleGastric BypassHumansInsulinInsulin-Like Growth Factor ILeptinMaleMiddle AgedNitric OxideObesity, MorbidWeight LossAdiponectinC-Reactive ProteinInsulinInsulin-Like Growth Factor ILeptinNitric Oxide

Identifiers

PMID20195789
OpenAlexW2044292893

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.